Different evasion strategies in multiple myeloma

Different evasion strategies in multiple myeloma

Multiple myeloma is the second most common malignant hematologic malignancy which evolved different strategies for immune escape from the host immune surveillance and drug resistance, including uncontrolled proliferation of malignant plasma cells in the bone marrow, genetic mutations, or deletion of...

Full description

Bibliographic Details
Main Authors:	Chaofan Wang, Wanting Wang, Moran Wang, Jun Deng, Chunyan Sun, Yu Hu, Shanshan Luo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-02-01
Series:	Frontiers in Immunology
Subjects:	multiple myeloma evasion extrinsic mechanism intrinsic mechanism immunology
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1346211/full

Similar Items

Peran religionsity sebagai pemoderasi hubungan money ethics terhadap upaya tax evasion
by: Rachmawati Meita Oktaviani, et al.
Published: (2018-04-01)

Sesquiterpene lactones as emerging biomolecules to cease cancer by targeting apoptosis
by: Chou-Yi Hsu, et al.
Published: (2024-03-01)

Hypersialylation and multiple myeloma
by: Michael O’Dwyer, et al.
Published: (2024-02-01)

Mechanisms of Immune Evasion in Multiple Myeloma: Open Questions and Therapeutic Opportunities
by: Cirino Botta, et al.
Published: (2021-06-01)

Clinical Considerations for Immunoparesis in Multiple Myeloma
by: Michael Chahin, et al.
Published: (2022-05-01)

Chimeric antigen receptor T cell therapies for multiple myeloma
by: Chao Wu, et al.
Published: (2019-11-01)

Chromosomal aberrations in multiple myeloma: A study on Indian population
by: Angel Beula P. Royal, et al.
Published: (2018-01-01)

Anaplastic morphology in IgD multiple myeloma
by: Verónica Roldán Galiacho, et al.
Published: (2023-10-01)

Targeting the Microenvironment for Treating Multiple Myeloma
by: Peter Neumeister, et al.
Published: (2022-07-01)

Biological basis of immunomodulatory preparations using in treatment of multiple myeloma
by: S. V. Semochkin
Published: (2022-11-01)

MANDİBULADA MULTİPL MYELOMA İKİ OLGU SUNUMU
by: Hümeyra Kocaelli
Published: (2005-05-01)

Multiple myeloma and kidney disease
by: Natalia Zarankiewicz, et al.
Published: (2022-08-01)

Multiple Myeloma: An Update
by: Khalil Al-Farsi
Published: (2013-01-01)

Immunoglobulin D Multiple Myeloma Presenting as Spontaneous Fracture
by: Samer Al Hadidi, et al.
Published: (2017-03-01)

DIFFUSE REFLECTION ELECTRON SPECTROSCOPY IN STUDY OF BLOOD SERUM WITH MULTIPLE MYELOMA
by: Liudmila V. Plotnikova, et al.
Published: (2020-04-01)

Emerging Therapeutic Strategies to Overcome Drug Resistance in Multiple Myeloma
by: Lorraine N. Davis, et al.
Published: (2021-04-01)

Pseudohypercalcemia in Multiple Myeloma: A Case Report
by: Farzaneh Ashrafi, et al.
Published: (2016-07-01)

How we manage smoldering multiple myeloma
by: Alessandra Romano, et al.
Published: (2020-09-01)

Myeloma /
by: 455001 Tanner, Jerome E., et al.
Published: (2008)

Genetic Abnormalities in Extramedullary Multiple Myeloma
by: Roisin McAvera, et al.
Published: (2023-07-01)

Editorial: Molecular Mechanisms of Multiple Myeloma
by: Alessandro Gozzetti, et al.
Published: (2022-03-01)

Pathogenesis and treatment of multiple myeloma
by: Peipei Yang, et al.
Published: (2022-06-01)

Multiple Myeloma Baseline Immunoglobulin G Level and Pneumococcal Vaccination Antibody Response
by: Michael A. Thompson, et al.
Published: (2017-08-01)

MMRFVariant: Prioritizing variants in Multiple Myeloma
by: Marzia Settino, et al.
Published: (2023-01-01)

Chimeric antigen receptor T-cell therapy for multiple myeloma
by: Zehua Wang, et al.
Published: (2022-12-01)

Lymphoplasmacytic variant of multiple myeloma
by: Silje Johansen, et al.
Published: (2022-05-01)

Macroglossia reveals multiple myeloma
by: Maria Bonvicini, et al.
Published: (2021-11-01)

Identification of the CD16low CD56low CD38pos Natural Killer Cell as a Key Subset in Patients with Multiple Myeloma
by: Ting Chen, et al.
Published: (2022-12-01)

The Impact of Motivation on the Work Performance of Health Workers (Korle Bu Teaching Hospital): Evidence from Ghana
by: Kofi Aduo-Adjei, et al.
Published: (2016-05-01)

Ixazomib in the treatment of relapsed multiple myeloma
by: S. V. Semochkin
Published: (2018-07-01)

IMMUNE DISTURBANCES IN PATIENTS WITH MULTIPLE MYELOMA
by: E. A. Senkina, et al.
Published: (2014-07-01)

Aggressive Multiple Myeloma with Unusual Morphology
by: Mehmet Sönmez, et al.
Published: (2014-12-01)

Carbamazepine and Multiple Myeloma: Possible Interaction
by: Meral Günaldı, et al.
Published: (2013-03-01)

Daratumumab‐based induction and autologous transplantation in concomitant multiple myeloma and chronic myeloid leukemia
by: Carmine Liberatore, et al.
Published: (2023-11-01)

Gamification Equilibrium: The Fulcrum for Balanced Intrinsic Motivation and Extrinsic Rewards in Learning Systems
by: Dah John, et al.
Published: (2023-09-01)

Thalidomide and its analogues in the treatment of Multiple Myeloma
by: Latif Tahir, et al.
Published: (2012-09-01)

The Many Faces of Multiple Myeloma
by: Asya Tuğçe Bol, et al.
Published: (2024-03-01)

The Versatility of Polymeric Materials as Self-Healing Agents for Various Types of Applications: A Review
by: Nik Nur Farisha Nik Md Noordin Kahar, et al.
Published: (2021-04-01)

Uterine Extramedullary Plasmacytoma as a Primary Manifestation of Multiple Myeloma
by: Ana Codorniz, et al.
Published: (2017-09-01)

Pomalidomide in the treatment of multiple myeloma: design, development and place in therapy
by: Rios-Tamayo R, et al.
Published: (2017-08-01)